Rega marang bathi mangsa ngarep: Prenetics Global (PRE)

Historical price action helps assess the effectiveness of the Prenetics Global (PRE) strategy, where the current indicator stands at 0.00. Prenetics Global (PRE) generates revenue through the sale of CircleDNA genetic tests and diagnostic services for clinics and individuals. The technical infrastructure relies on updated DNA sequencers and automated sample sorting, providing laboratories with excellent operational efficiency and stable capacity utilization.

PRE - Kapitalisasi marang proyeksi bathi prenetics.com ing rentang 28.04.2023 - 12.11.2026

Prenetics Global Ltd - rincian analitis lan metrik utama (PRE)

- rega saiki lan proyeksi nilai saham:

Kutipan saham Prenetics Global|PRE - Rata-rata rega prakiraan

- indikator kapitalisasi bursa perusahaan:

Nilai pasar Prenetics Global Limited|PRE - Rega Tumbas Perusahaan

- data ekuitas miturut neraca:

Nilai Buku saben Saham Prenetics|PRE - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku prenetics.com|PRE - Gunggung Aset Perusahaan

- rincian utang lan likuiditas:

- statistik bathi lan rasio pasar:

PRE - Penghasilan resik perusahaan|Bathi mangsa ngarep Prenetics Global|PRE - Rasio rega pasar marang bathi resik|Pangali Forward P/E Prenetics Global|PRE - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Prenetics Global Limited|PRE - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Prenetics|PRE - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan prenetics.com|PRE - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Prenetics Global

Pambiji fundamental:Prenetics

Prenetics Global revenues depend on scaling CircleDNA test sales across Asian and European markets. By analyzing the issuer's forward P/E, an investor assesses the current share price relative to expected earnings. This chart smooths out market noise by connecting equilibrium points to identify the long-term valuation trend. This approach prevents the purchase of an overvalued asset at the cycle peak. This indicator determines the fundamental attractiveness of the securities within the genomics sector.

Pesaing Prenetics Global (PRE)